A $2 million, two-year research project hopes to find proteins in blood that could alert doctors to patients harboring not just breast cancer, but the nastiest versions of the disease. The project takes advantage of a comprehensive collection of 30,000 breast cancer clinical samples, located at the Walter Reed-Windber Clinical Breast Care Project in Washington, D.C., and Windber, Penn., and advanced proteomics technology at the Department of Energy's Pacific Northwest National Laboratory in Richland, Wash.